This study is examining the near-term effects of the self-directed format of the program on improvements in primary outcomes of pain, stiffness, fatigue; secondary outcomes of self-reported physical and psychosocial functioning, and program satisfaction. Dr. Alfredo Rivadeneira is a Co-Investigator on the project.
To date, Dr. Callahan and her team have recruited 80 participants in CELAH (Center for Latino Health) Clinics at UNC (Rheumatology, Geriatrics, Internal Medicine, Orthopaedics, Gastrointestinal) and at a Health Fair for Latino Women at the St. Thomas More Church. The team plans to include recruitment outreach at Triangle area churches, the Mexican Consulate in Raleigh and Bethesda Health Center in Charlotte. Dr. Callahan was the Principal Investigator for the Arthritis Foundation’s “Evaluation of Walk with Ease in Arthritis” which established the evidence base for the program among people with arthritis.
Joanne M. Jordan, MD, MPH
Leigh F. Callahan, PhD
Kelli Allen, PhD
Yvonne Golightly, PT, MS, PhD
Maya R. Jerath, MD, PhD
Beth L. Jonas, MD
Edwin H. Kim, MD, MS
Richard F. Loeser, Jr., MD
Amanda E. Nelson, MD, MSCR, RhMSUS
Jennifer L. Rogers, MD
Robert Roubey, MD
Saira Z. Sheikh, MD
Maureen Su, MD, AM
Teresa Tarrant, MD
William Yount, MD
Mary Altpeter - Co-investigator, Callahan and Rini Teams
Diane Bresch, BSN, RN - Coordinator, Clinical Trials Team
Monica Jin, PhD - Postdoctoral Fellow, Liu Lab
Denise Allard Trout - Su Lab
Lee Kyung Hong - Su Lab
Matthew Billard, PhD - Postdoctoral Researcher, Tarrant Lab
Jaime Brozowski, MS - Graduate Research Assistant, Tarrant Lab
Aaron Kobernick, MD – 1st year Allergy/Immunology Fellow
Joanne M. Jordan, MD MPH, Chief of the Division of Rheumatology, Allergy and Immunology and Director of the Thurston Arthritis Research Center was inducted into The American Clinical and Climatological Association in October. Marc Hochberg, MD MPH, Marschall Runge, MD PhD and John Winfield, MD sponsored Dr. Jordan’s membership into the oldest medical society in the country.
The American Clinical and Climatological Association was organized in 1884 by a group of physicians and scientists who set about to improve medical education, research and practice in this country. Its initial concern was with tuberculosis and its treatment by residence in a suitable climate. Throughout its long history, the Association has expanded its interests to all scientific and clinical aspects of medicine and its specialties as well as epidemiology, preventive and environmental medicine, while retaining a continuing interest in the influence of global climate changes on health and disease. Its membership comprises outstanding physicians selected on the basis of their leadership, their excellence in their chosen field, their demonstrated high level of integrity and professionalism, and their yearning to nurture a spirit of warmth, diversity and friendship. The annual meeting of the Association provides an opportunity for presentation and critical discussion of the most recent progress in research, practice and teaching. It is devoted to the scientific understanding and to the compassionate care of human disease. The meeting also serves to reaffirm the values and the principles of the Association. Active membership is limited to 250 physicians.
Dr. Hochberg is a Professor of Medicine and Epidemiology & Preventive Medicine at the University of Maryland School of Medicine Head of the Division of Rheumatology and Clinical Immunology in the Department of Medicine at the University of Maryland School of Medicine.
Dr. Runge is the Executive Dean for the UNC School of Medicine, Chair of the Department of Medicine and Principal Investigator and Director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at UNC-CH.
Dr. Winfield is a retired rheumatologist, former Chief of the Division of Rheumatology and Immunology and Founding Director of the Thurston Arthritis Research Center.
The Lifetime Achievement Award is presented to a current or former member of ACR/ARHP whose career has demonstrated a sustained and lasting contribution to the field of rheumatology and rheumatology health professionals.
Dr. Joanne Jordan nominated Dr. Callahan for the prestigious award and says, “Dr. Callahan’s entire professional career has focused on the advancement of arthritis research, advocacy for the importance of this chronic disease to the nation’s public health agenda, and devotion to recruiting and mentoring multidisciplinary researchers in the arthritis mission. She sparkles with energy that is infectious to all around her and is tireless in championing the priorities of arthritis-related initiatives.”
Dr. Callahan is also a Professor of Social Medicine, and an adjunct professor in the Department of Epidemiology in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. She is Associate Director of Epidemiology and Outcomes Research and the Associate Director of the Multidisciplinary Clinical Research Center at the UNC Thurston Arthritis Research Center. She also directs the Osteoarthritis Action Alliance (OAAA), which was recently acquired by UNC Thurston Arthritis Research Center from the Arthritis Foundation. Dr. Callahan has an undergraduate degree from UNC and a PhD from Vanderbilt University. She has over 30 years of experience in arthritis and health outcomes research, and experience in public health as a former arthritis epidemiologist with the Centers for Disease Control and Prevention.
Dr. Callahan has served on a number of editorial boards, is a former editor for the Arthritis Care and Research journal and has been a reviewer for numerous journals including the Journal of Rheumatology, Arthritis and Rheumatism, JAMA, Annals of Internal Medicine, and Medical Care. She recently served on the Institute of Medicine (IOM) committee that produced the report, Living well with chronic illness: A call for public health action. She formerly served on the United States Bone and Joint Initiative (USBJI) Board of Directors and is on the Steering Committee of the USBJI’s Chronic Osteoarthritis and Management Initiative (COAMI). She is a member of the Non-Pharmacologic Trials Working Group of the Osteoarthritis Research Society International (OARSI) Guidelines for Conducting Clinical Trials in Osteoarthritis Committee. Dr. Callahan is a long-time volunteer for the Arthritis Foundation (AF) on both the state and national level, and received the Charles B. Harding Award for Distinguished Service in 2005 for her work with the Foundation. In 2006, she received the Addie Thomas Service Award from the Association of Rheumatology Health Professionals. She has authored more than 200 research articles, book chapters, commentaries and editorials. She is a frequent presenter at conferences and meetings worldwide, and continues to spearhead a number of projects examining the factors surrounding arthritis, epidemiology, health outcomes, and health disparities. She has received numerous grants from the NIH, CDC and Arthritis Foundation.
Leigh F. Callahan, PhD, will serve as Director for the OAAA
The OAAA is a national coalition of concerned organizations mobilized by the Arthritis Foundation and the Centers for Disease Control and Prevention (CDC). This coalition is committed to elevating osteoarthritis (OA) as a national health priority and promoting effective policy solutions that aim to address the individual and national toll of OA.
“Under the leadership of Drs. Joanne Jordan and Leigh F. Callahan at UNC, the Thurston Arthritis Research Center is uniquely positioned to take on the OAAA,” said Melanie Thompson, Osteoarthritis Action Alliance manager at the Arthritis Foundation.
“They currently have a National Institute of Arthritis and Musculoskeletal and Skin Diseases-funded Multidisclipinary Clinical Research Center (MCRC) titled ‘Mitigating the Public Health Impact of Osteoarthritis,’ and the OAAA goals are completely congruent with the goals of the MCRC.
The MCRC draws together multiple units and investigators at UNC interested in OA into novel collaborative relationships. Dr. Callahan was also part of the Steering Committee for the National Public Health Agenda for Osteoarthritis and has been involved in the OAAA since the beginning. The Arthritis Foundation remains committed to the OAAA and will provide UNC financial support to lead the OAAA through a cooperative agreement with the CDC,” Thompson said.
Leigh F. Callahan, PhD, the Mary Link Briggs Distinguished Professor of Medicine at the UNC Thurston Arthritis Research Center, will serve as Director of the OAAA. “We are thrilled to be selected to bring this consortium to UNC and the Thurston Arthritis Research Center,” said Joanne M. Jordan, MD, MPH, the Joseph P. Archie, Jr. Eminent Professor of Medicine, Chief of the Division of Rheumatology, Allergy and Immunology and Director of the Thurston Arthritis Research Center. “Dr. Callahan is the perfect leader for this initiative, which will dovetail beautifully with other efforts we have undertaken to improve the care of people with osteoarthritis or at high risk for osteoarthritis.”
Dr. Mary Goldring (left) nominated and introduced Dr. Loeser (center) and Dr. Virginia Kraus (right) is the President of OARSI and presented the award.
On April 24, Dr. Loeser received the Basic Science Research Award from the Osteoarthritis Research Society International (OARSI) World Congress in Paris, France.
Dr. Loeser is the Herman and Louise Smith Distinguished Professor of Medicine in our division and Director of Basic and Translational Research in our center. He was honored "for outstanding work in helping to improve our understanding of the basic mechanisms by which aging contributes to the development of osteoarthritis."
The purpose of the OARSI Basic Science Research Award is to promote advancement in basic research in the field of osteoarthritis. Research targets include all areas of basic science with relevance to osteoarthritis and in a number of specialty disciplines having an interest in osteoarthritis. This research has primarily been conducted within the last five years.
We are extremely pleased to announce that Richard Loeser, MD, joined the Division of Rheumatology, Allergy and Immunology and the Thurston Arthritis Research Center on Monday, March 3, 2014. Dr. Loeser is a rheumatologist and was previously the Dorothy Rhyne and Willard Duke Kimbrell Professor at Wake Forest University School of Medicine, where he also served as Section Head of Molecular Medicine.
Upon his arrival at the Thurston Arthritis Research Center, Dr. Loeser was awarded the Herman and Louise Smith Distinguished Professor of Medicine and appointed as the Director of Basic and Translational Research. He will be an active partner in our mission to serve patients, lead and conduct research, and mentor trainees in our Division and the Department of Medicine.
Once settled at UNC, Dr. Loeser will recruit three additional basic and translational research faculty members to the Thurston Arthritis Research Center. We are fortunate that he brought several valuable colleagues with him to Chapel Hill. Scott Wood, a post-doctoral student; Meredith Greene, a graduate student; and Y (Mary) Zhao and Kathryn Kelley, both laboratory technicians. Dr. Loeser, his faculty recruits and all associated staff and students will be housed on the fourth floor of the Thurston Building.
Dr. Loeser’s translational research interests include osteoarthritis, aging, inflammatory diseases, and cell signaling. His laboratory has studied the basic biology of healthy cartilage cells in joints for over 20 years, was the first to describe certain types of cell receptors, and has published over 100 original manuscripts on these topics, among others. Dr. Loeser is the Principle Investigator on multiple, currently-funded NIH grants studying cell signaling pathways and molecular mechanisms involved in the development of osteoarthritis. Dr. Loeser looks forward to active collaboration with multiple groups across the Schools of Medicine and Dentistry, and the Gillings School of Global Public Health, including the Center on Aging, the Departments of Orthopedics, Pediatrics, Cell Biology and Physiology, Biomedical Engineering, and the Lineberger Comprehensive Cancer Center.
I hope you will join in our excitement in welcoming Dr. Loeser as his leadership will be transformative for our Division and our Center.